Quarterly report [Sections 13 or 15(d)]

Net Loss Per Share - Schedule of Outstanding Shares of Potentially Dilutive Securities (Details)

v3.26.3
Net Loss Per Share - Schedule of Outstanding Shares of Potentially Dilutive Securities (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 19,167,878 18,796,272 19,167,878 18,796,272
Options to purchase common stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 2,014,096 2,033,114 2,014,096 2,033,114
Warrants to purchase common stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 478,419 478,419
Restricted Stock Units [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 1,334,965 3,677 1,334,965 3,677
Common stock issuable upon conversion of Series B-1 convertible preferred stock        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities
Common stock issuable upon conversion of Series A-2 Prime convertible preferred stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 462,245 462,245
Warrants to purchase convertible preferred stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 15,818,817 15,818,817 15,818,817 15,818,817